Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).

Trial Profile

Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Carboplatin (Primary) ; Irinotecan (Primary)
  • Indications Small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Oct 2016 Final analysis results assessing safety and efficacy presented at the 41st European Society for Medical Oncology Congress.
    • 26 Sep 2015 Status changed from recruiting to completed, as per University Hospital Medical Information Network - Japan record.
    • 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top